Showing results (11-20 of 677) with videos related to
Sort By:
Pageof 68
European Journal of Clinical Pharmacology|January 1, 1983
Bioavailability of drugs with long elimination half-livesR Urso, L AaronsXenobiotica; the Fate of Foreign Compounds in Biological Systems|October 31, 2007
Design of population pharmacokinetic experiments using prior informationK Ogungbenro, L AaronsIET Systems Biology|January 22, 2009
Proper lumping in systems biology modelsA Dokoumetzidis, L AaronsJournal of Pharmacokinetics and Biopharmaceutics|October 17, 1998
The pharmacokinetics of saquinavir: a Markov chain Monte Carlo population analysisD J Lunn, L AaronsThe Journal of Pharmacy and Pharmacology|October 1, 1989
A note on the use of salicylate saliva concentration in clinical pharmacokinetic studiesA Z Khan, L AaronsEuropean Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 6, 2000
Development of a sequential linked pharmacokinetic and pharmacodynamic simulation model for ivabradine in healthy volunteersS B Duffull, L AaronsJournal of Theoretical Biology|September 22, 1989
Design and analysis of protein binding experimentsA Z Khan, L AaronsPharmaceutical Research|May 1, 1989
Efficiency of drug targeting: steady-state considerations using a three-compartment modelA Boddy, L Aarons, K PetrakPharmaceutical Research|December 20, 1999
A pharmacokinetic model for tenidap in normal volunteers and rheumatoid arthritis patientsL Evans, L Aarons, P CoatesJournal of Pharmacokinetics and Biopharmaceutics|April 17, 1999
Quantitative structure-pharmacokinetics relationships: II. A mechanistically based model to evaluate the relationship between tissue distribution parameters and compound lipophilicityI Nestorov, L Aarons, M RowlandPageof 68